1. Home
  2. NEWT vs CCCC Comparison

NEWT vs CCCC Comparison

Compare NEWT & CCCC Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.

Logo NewtekOne Inc.

NEWT

NewtekOne Inc.

N/A

Current Price

$12.11

Market Cap

400.6M

Sector

Finance

ML Signal

N/A

Logo C4 Therapeutics Inc.

CCCC

C4 Therapeutics Inc.

N/A

Current Price

$3.44

Market Cap

404.7M

Sector

Health Care

ML Signal

N/A

Company Overview

Basic Information
Metric
NEWT
CCCC
Founded
1998
2015
Country
United States
United States
Employees
N/A
N/A
Industry
Major Banks
Biotechnology: Pharmaceutical Preparations
Sector
Finance
Health Care
Exchange
Nasdaq
Nasdaq
Market Cap
400.6M
404.7M
IPO Year
2013
2020

Fundamental Metrics

Financial Performance
Metric
NEWT
CCCC
Price
$12.11
$3.44
Analyst Decision
Buy
Strong Buy
Analyst Count
3
6
Target Price
$15.33
$12.20
AVG Volume (30 Days)
244.1K
2.3M
Earning Date
04-30-2026
05-06-2026
Dividend Yield
6.00%
N/A
EPS Growth
11.22
16.45
EPS
0.90
N/A
Revenue
N/A
$35,947,000.00
Revenue This Year
N/A
N/A
Revenue Next Year
$12.45
N/A
P/E Ratio
$13.70
N/A
Revenue Growth
N/A
1.02
52 Week Low
$9.59
$1.69
52 Week High
$15.69
$5.17

Technical Indicators

Market Signals
Indicator
NEWT
CCCC
Relative Strength Index (RSI) 37.44 36.66
Support Level $11.47 $3.40
Resistance Level $12.38 $3.91
Average True Range (ATR) 0.29 0.22
MACD 0.06 -0.07
Stochastic Oscillator 48.18 1.74

Price Performance

Historical Comparison
NEWT
CCCC

About NEWT NewtekOne Inc.

NewtekOne Inc provides business and financial solutions under the Newtek and NewtekOne brands to the independent business owner (SMB) market. Its services are offered online and in some cases delivered by staff via video and voice calls. The company offers lending products, FDIC insured deposit products and services, payments processing, payroll services and insurance brokerage services. Loan products include SBA 7(a), ALP, SBA 504, and traditional C&I and CRE bank loans, while deposit products include consumer high yield savings accounts, high yield certificates of deposit, zero-fee business checking and business money market accounts. The company operates through four reportable segments Banking, Alternative Lending, NSBF and Payments.

About CCCC C4 Therapeutics Inc.

C4 Therapeutics Inc is a clinical-stage biopharmaceutical company dedicated to delivering on the promise of targeted protein degradation science to create a new generation of medicines that transforms patient's lives. The Company is progressing targeted oncology programs through clinical studies and leveraging its TORPEDO platform to efficiently design and optimize small-molecule medicines to address difficult-to-treat diseases. The degrader medicines of the company are designed to harness the body's natural protein recycling system to rapidly degrade disease-causing proteins, offering the potential to overcome drug resistance, and drug undruggable targets and improve patient outcomes. Its pipeline is Cemsidomide, CFT8919, and other discovery products.

Share on Social Networks: